Category Archives: Health

Latest From Health

NYT Columnist: Insurance Industry “Looking at the Costs of Sovaldi in the Wrong Way”

New York Times Building

Margot Sanger-Katz’s article on a new drug that treats hepatitis C notes that despite the attention the cost has received to date, those attacking the drug are “looking at the costs of Sovaldi in the wrong way.” Sanger-Katz acknowledges that these one-time treatments can be a ‘shock to the system,’ but notes the value far outweighs the expense since it cures the disease in the majority of patients, preventing further costly treatments and care. Sanger-Katz Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Treating Hepatitis C: Too Costly Not to Act

CHI

Today, The Hill published an op-ed – Treating hepatitis C: Too costly not to act – by California Healthcare Institute’s Todd Gillenwater on the value of breakthrough Hepatitis C medicines that cure the disease in the majority of patients. As Gillenwater asserts, “New hepatitis C drugs mark a paradigm shift – from a model of somewhat iffy but costly chronic care to a model of short-term curative treatment with equal or slightly lower costs paid Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , ,

New Report: Innovation in Hepatitis C Treatment

CHI

Today, the California Healthcare Institute released a report on the public health impact of Hepatitis C and the potential of groundbreaking new treatments to save tens of thousands of lives over the coming decades. Innovation in Hepatitis C Treatment: New Opportunities for Action explores the incredible progress that has been made in Hepatitis C treatment in the decades since the Hepatitis C virus was identified as the cause of the disease in 1989. Early treatments Read More >

Health, Public Policy  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

BioCentury TV This Week: 340B Drug Discount Program Needs More Oversight

Todd

BIO’s Laurel Todd shared concerns that the 340B program has departed significantly from its original intent, leading to evidence of abuse and potentially harmful consequences for patients. “The original intent of 340B was to support the most vulnerable patients; clearly that is not the focus for many of the participants in the program now,” said Todd. Todd pointed to three primary reasons the program needs more oversight: Exponential growth, significant violations revealed in audits, and Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Beggar-Thy-Neighbor Medicine: Wall Street Journal Op-Ed

medicine-thumb

In an editorial about specialty drug prices, the Wall Street Journal writes: “To understand how ObamaCare is already bending the future of U.S. medical progress, consult the furor over specialty drug prices, as an alliance of convenience among third-party payers assails pharmaceutical innovation as too costly. Maybe patients should give up on cures and, as President Obama once put it, just take the painkiller…” Read the full opinion

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,